Biotech Idorisa Pharmaceuticals News Portfolio

Idorsia Stock Explodes After Insomnia Drug Hits Primary Endpoint in Phase 3 Trial

Biotech News | 21.04.2020

Shares of the Swiss biotech Idorisa increase by more than 13% after the company has announced that...

Alnylam Pharmaceuticals Biotech News Portfolio Vir Biotechnology

Alnylam and Vir Expand Collaboration to Develop RNAi Therapeutics for Coronavirus Infection

Biotech News | 06.03.2020

Alnylam Pharmaceuticals and Vir Biotechnology expand their collaboration to advance siRNA...

Biotech News Portfolio Sangamo Therapeutics

Sangamo Therapeutics: $2.7 Billion Deal with Biogen for Neurodegenerative Disorders

Biotech News | 02.03.2020

Sangamo Therapeutics and Biogen announced a global licensing collaboration deal for the development...

Biotech GW Pharmaceuticals Portfolio Stock Recommendations

GW Pharmaceuticals: One of the Top Biotech Stocks for 2020

Biotech News | 26.02.2020

In the period of May to December 2019, shares of GW Pharmaceuticals had to suffer a major setback...

Biotech Esperion Therapeutics News Portfolio

FDA Approves Esperion’s Cholesterol-Lowering Drug Nexletol

Biotech News | 25.02.2020

The US Food and Drug Administration approves Esperion’s oral LDL-Cholesterol (LDL-C) lowering...

Biotech Incyte News Portfolio

Incyte With Second Positive Pivotal Trial in Atopic Dermatitis (Eczema)

Biotech News | 19.02.2020

Incyte today announced that also the second of two identical phase 3 trials with Ruxolitinib cream...

Biotech GW Pharmaceuticals News Portfolio

GW Pharmaceuticals Jumps 7%: Is Now the Time to Buy this Stock?

Biotech News | 08.02.2020

Shares of GW Pharmaceuticals, a global leader in cannabinoid-based medicines and member of our...

Biotech Incyte News Portfolio

Incyte With Second Positive Phase 3 Trial in Atopic Dermatitis Within Two Days

Biotech News | 28.01.2020

These are truly exciting days for Incyte. The American biopharmaceutical company and member of our...

Biotech Eli Lilly Incyte News Portfolio

Eli Lilly and Incyte’s Olumiant Clears Pivotal Trial in Atopic Dermatitis

Biotech News | 27.01.2020

Incyte and Eli Lilly today announced the results from a phase 3 clinical trial with Olumiant...

Biotech Hutchinson China Meditech News Portfolio

Hutchison China Meditech Stops Phase 3 Trial in Pancreatic Cancer Upon Early Success

Biotech News | 21.01.2020

Hutchison China Meditech, also known as Chi-Med, has terminated a phase 3 clinical trial with...

Biotech Lonza News Portfolio

Lonza Group’s Share Jumps: Higher Profit and Focus on Biotech

Biotech News | 21.01.2020

The Swiss Lonza Group, a leading supplier to the pharmaceutical and biotech industry and member of...

Biotech Evotec News Portfolio

Evotec Exceeds Expectations: The Specialist for Biologics Is on Track

Biotech News | 20.01.2020

Thanks to good business in the fourth quarter and unexpectedly high milestone payments, the...

Biotech News Portfolio

Biotech Investments Model Portfolio: +26.1% in 2019!

Biotech News | 31.12.2019

The year 2019 was once again a very successful one. The performance of the Biotech Investments...

Biotech Macrogenics News Portfolio

Macrogenics Submits Biologics License Application for Margetuximab to FDA

Biotech News | 19.12.2019

Macrogenics, the US oncology company and member of our Biotech Investments Model Portfolio, today...

Agios Pharmaceuticals Biotech News Portfolio

Agios Pharmaceuticals: FDA Breakthrough Therapy Designation for Tibsovo in Myelodysplastic Syndrome

Biotech News | 18.12.2019

Agios Pharmaceuticals’ cancer drug Tibsovo is granted FDA breakthrough therapy designation for...

Alnylam Pharmaceuticals Biotech News Portfolio

Alnylam Reports Positive Phase 3 Results for its ILLUMINATE-A Trial of Lumasiran in Primary Hyperoxaluria

Biotech News | 17.12.2019

The US biotech company and specialist in RNA interference therapies Alnylam Pharmaceuticals today...

Biotech News Portfolio Sarepta Therapeutics

Sarepta: Share Price Explosion after FDA Hammer! And now?

Biotech News | 15.12.2019

There is only one suitable word for yesterdays’ news: sensation! The American healthcare...

Audentes Therapeutics Biotech News Portfolio

Astellas Pharma to Buy Audentes for $3 Billion: +270 since January 2019%!

Biotech News | 02.12.2019

We have to say goodbye to our Biotech Investments Model Portfolio member Audentes Therapeutics. The...

Biotech News Portfolio

Biotech Investments Model Portfolio: +23.1% as of November 30!

Biotech News | 01.12.2019

Biotech Investments' Model Portfolio performance is +23.1% as of November 30. This corresponds to...

Biotech Corbus Pharmaceuticals News Portfolio

Corbus Pharmaceuticals Presents Phase 2 OLE Data for Lenabasum: Is This Stock a Buy Now?

Biotech News | 11.11.2019

Corbus Pharmaceuticals today presented the open-label-extension (OLE) data from its two phase 2...

Biotech News Portfolio Science and Medicine Vertex Pharmaceuticals

Vertex Pharmaceuticals and Trikafta: Hope for Patients With Cystic Fibrosis

Biotech News | 10.11.2019

  The US Food and Drug Administration FDA has approved a drug against cystic fibrosis that...

Biotech Incyte News Portfolio

Incyte Opts for Switzerland as its New European Headquarters

Biotech News | 10.11.2019

The American biotech company Incyte has chosen the Swiss city Morges as its European headquarters....

Biotech Esperion Therapeutics News Portfolio

Esperion Therapeutics to Present Pooled Analyses from its Phase 3 Trials with Bempedoic Acid at AHA Congress

Biotech News | 04.11.2019

Esperion Therapeutics today announced that it will present a pooled analysis of its 4 phase 3...

Amgen BeiGene Biotech News Portfolio

Hammer Deal: Amgen Joins Model Portfolio Member BeiGene – Share Explodes 37 Percent!

Biotech News | 01.11.2019

The biotech giant Amgen wants to increase its presence in China. The Americans will buy 20.5% of...

Biotech News Portfolio

Biotech Investments Model Portfolio: +4.1% as of October 31

Biotech News | 31.10.2019

Biotech Investments' Model Portfolio performance is +4.1% as of October 31. This corresponds to an...

Biotech CRISPR Therapeutics News Portfolio Vertex Pharmaceuticals

Takeover Rumors about CRISPR Therapeutics: Does Vertex Make a Move?

Biotech News | 30.10.2019

As a result of new takeover rumors, CRISPR Therapeutics’ share price has increased more than 27%...

Biotech Macrogenics News Portfolio

Pfizer Stops Collaboration with Macrogenics on a Bispecific Antibody for Solid Tumors

Biotech News | 29.10.2019

Macrogenics has to digest a severe setback as Pfizer plans to stop a collaboration on a bispecific...

Agios Pharmaceuticals Portfolio Stock Recommendations

Agios Pharmaceuticals: Buy! One of the Top Biotech Stocks!

Biotech News | 26.10.2019

Since the beginning of April 2019, the stock of Agios Pharmaceuticals has known only one direction:...

Biotech Macrogenics News Portfolio

Macrogenics Stocks Down 15% after Presentation of Updated Survival Data for Margetuximab

Biotech News | 23.10.2019

Shares of the Biotech Investments Model Portfolio member Macrogenics are down 15% to $9.38 today...

Alexion Pharmaceuticals Biotech News Portfolio

FDA Approves Alexion’s Ravulizumab for Atypical Hemolytic Uremic Syndrome

Biotech News | 19.10.2019

The US healthcare authority FDA on Friday approved Alexion Pharmaceuticals’ drug Ravulizumab for...

Alexion Pharmaceuticals Biotech News Portfolio

Alexion with $930 Million Takeover of Achillion Pharmaceuticals to Expand Drug Pipeline for Rare Immunological Diseases

Biotech News | 16.10.2019

The big merger and acquisition (M&A) wave in biotech industry continues. Alexion...

Biotech Incyte News Portfolio

Incyte’s Ruxolitinib Cream with Positive Phase 2 Trial in Vitiligo

Biotech News | 14.10.2019

A phase 2 clinical trial with Incyte’s Ruxolitinib cream in patients with vitiligo met its...

Biotech Ionis Pharmaceuticals News Portfolio

Bayer Advances with Ionis’ Factor XI Anti-Thrombotic Drug

Biotech News | 09.10.2019

Ionis Pharmaceuticals, a leader in antisense therapy with a pipeline of more than 40 drug...

Akcea Therapeutics Biotech Portfolio What's up

This is the Reason why Akcea Therapeutics’ Share Explodes: +35% Today!

Biotech News | 07.10.2019

Shares of Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals and member of our Biotech...

Biotech News Portfolio Sangamo Therapeutics

Sangamo Therapeutics Hires New Chief Medical Officer

Biotech News | 01.10.2019

Sangamo today announced Bettina Cockroft as a new chief medical offier for its gene editing...

Biotech News Portfolio Vertex Pharmaceuticals

Vertex Pharmaceuticals Appoints Carmen Bozic as New Chief Medical Officer

Biotech News | 01.10.2019

Vertex Pharmaceuticals' today announced Carmen Bozic as a successor of the previous chief medical...

Biotech Hutchinson China Meditech News Portfolio

CK Hutchison Offers 1.3% of Hutchison China Meditech’s Share Capital

Biotech News | 30.09.2019

Hutchison China Meditech Limited, also known as Chi-Med, today announced in London that its...

Agios Pharmaceuticals Biotech News Portfolio

Agios’ Drug Tibsovo Prolongs Progression-Free Survival in Phase 3 Cholangiocarcinoma Trial by only 2 Months, Shares Down by 6%

Biotech News | 30.09.2019

Agios Pharmaceuticals today announced the presentation of phase 3 clinical trial data for Tibsovo....

Biotech Macrogenics News Portfolio

Macrogenics Presents Updated Analysis of its Phase 2 Trial with Margetuximab in Metastatic Gastroesophageal Cancer: Share Gains more than 4%

Biotech News | 30.09.2019

Macrogenics, a US biotechnology company focusing on the development of novel antibody therapies for...

Biotech News Portfolio

Biotech Investments Model Portfolio: +3.1% as of September 29

Biotech News | 29.09.2019

The Performance of Biotech Investments Model Portfolio is +3.1% as of September 29. After a...

Biotech Incyte News Portfolio

Incyte with Positive Results from Phase 2 Trial of Pemigatinib in Advanced Cholangiocarcinoma

Biotech News | 27.09.2019

The US pharmaceutical company Incyte, a member of our Biotech Investments Model Portfolio which is...

Biotech Incyte News Portfolio

Incyte Announces Successful Initiation of Phase 3 Program with Ruxolitinib Cream for Patients with Vitiligo

Biotech News | 25.09.2019

The US pharmaceutical company Incyte today released an announcement saying that the phase 3...

Akcea Therapeutics Biotech News Portfolio

Akcea Therapeutics Appoints Damien McDevitt as Interim CEO

Biotech News | 23.09.2019

Akcea Therapeutics, a Cambridge-based affiliate of Ionis Pharmaceuticals specialized on the...

Evotec Portfolio Stock Recommendations

Evotec: Buy!

Biotech News | 20.09.2019

Our society wants to live healthier and is getting older and older. This development holds enormous...

Biotech News Portfolio Vertex Pharmaceuticals

Quo Vadis, Vertex Pharmaceuticals?

Biotech News | 18.09.2019

The Boston-based US biopharmaceutical company Vertex Pharmaceuticals, specialized in the treatment...

Biotech CRISPR Therapeutics News Portfolio

CRISPR Therapeutics and ViaCyte Present Promising In-Vitro Data Towards a Potential Diabetes Cure

Biotech News | 17.09.2019

CRISPR Therapeutics, a company specialized on gene therapies for severe diseases using a...

Alnylam Pharmaceuticals Biotech News Portfolio

Alnylam Pharmaceuticals Initiates New Phase 3 Trial of Patisiran for the Treatment of Patients with Transthyretin Amyloidosis with Cardiomyopathy

Biotech News | 16.09.2019

Alnylam Therapeutics, a leading RNA interference company and member of our Biotech Investments...

Akcea Therapeutics Biotech News Portfolio

Akcea Therapeutics Presents Positive Phase 1 Results for its Transthyretin Amyloidosis Drug AKCEA-TTR-LRx

Biotech News | 16.09.2019

The Boston-based US biotechnology company Akcea Therapeutics today presented positive results of a...

Biotech News Portfolio

Alnylam Pharmaceuticals Adds an Additional Piece of Evidence to the Pathogenic Role of the V122I Mutation of Transthyretin

Biotech News | 13.09.2019

The Cambridge-based US biopharmaceutical company Alnylam Pharmaceuticals, a market leader in RNA...

Biotech News Portfolio

BioSpace Article on the Top Takeover Targets: 4 out of 10 Companies Are Part of the Biotech Investments Model Portfolio

Biotech News | 11.09.2019

BioSpace, a mouthpiece for news from the biotech industry, today released an interesting article on...

BeiGene Biotech News Portfolio

BeiGene Has to Defend Against Short Report, Share Plunges

Biotech News | 10.09.2019

BeiGene, the outstanding example of the fast-developing Chinese biotech industry and member of the...

Biotech News Portfolio

Biotech Investments Model Portfolio: +14.8% as of August 31

Biotech News | 05.09.2019

The Performance of Biotech Investments Model Portfolio is +14.8% as of August 31. Although this...

Biotech News Portfolio Vertex Pharmaceuticals

Vertex Pharmaceuticals Pays $950 Million for Stem Cell Player Semma Therapeutics

Biotech News | 03.09.2019

Vertex Pharmaceuticals, the US cystic fibrosis specialist and member of our Biotech Investments...

Biotech Esperion Therapeutics News Portfolio

Esperion’s Cholesterol-Lowering Drug Bembedoic Acid With Positive Top-Line Results from Phase 2 Trial in Patients with Type 2 Diabetes

Biotech News | 29.08.2019

Esperion Therapeutics, a US-based pharmaceutical company specialized in the development of oral...

Biotech Kezar Life Sciences News Portfolio

Kezar Life Sciences Share still under Strong Pressure

Biotech News | 27.08.2019

Kezar Life Sciences is currently still in a difficult position on the stock exchange. The...

Alexion Pharmaceuticals Biotech News Portfolio

Takeover Rumors Boost Alexion Pharmaceuticals Share

Biotech News | 23.08.2019

The share price of our sample portfolio member Alexion Pharmaceuticals exploded this week. The...

Biotech News Portfolio Sarepta Therapeutics

Sarepta Therapeutics: FDA Refuses Marketing Approval for Duchenne Drug Golodirsen

Biotech News | 19.08.2019

The gene therapy powerhouse Sarapta Therapeutics and member of our Model Portfolio has to digest...

Biotech News Portfolio Sarepta Therapeutics

Sarepta after Drop in Share Price: CEO Ingram Now Buys on a Grand Scale

Biotech News | 13.08.2019

After a patient developed a severe side effect in a gene therapy study, the Sarepta share price...

Biotech News Portfolio Sarepta Therapeutics

Sarepta Comments on Incorrect Submission to FDA’s FEARS Adverse Events Reporting System

Biotech News | 08.08.2019

Sarepta Therapeutics, a leading provider of gene therapy for rare diseases and a member of our...

Audentes Therapeutics Biotech News Portfolio

Audentes Therapeutics Publishes Business and Pipeline Update for Second Quarter 2019

Biotech News | 06.08.2019

Audentes Therapeutics, a member of our Model Portfolio specializing in the development of gene...

Agios Pharmaceuticals Biotech News Portfolio

Encouraging Second Quarter for Agios Pharmaceuticals: IDH inhibitor Tibsovo Shows Strong Growth

Biotech News | 01.08.2019

Agios Pharmaceuticals, a company specializing in the development of oncology and rare genetic...

Biotech News Portfolio Vertex Pharmaceuticals

Vertex Pharmaceuticals Increases Sales by 25% in the Second Quarter of 2019

Biotech News | 01.08.2019

Vertex Pharmaceuticals yesterday evening announced its financial results for the second quarter of...

Biotech Macrogenics News Portfolio

Macrogenics Publishes Business and Pipeline Update for the Second Quarter of 2019, Share Price Falls Slightly

Biotech News | 31.07.2019

Our Model Portfolio member Macrogenics, which specializes in the development of innovative antibody...

Biotech Incyte News Portfolio

Model Portfolio Member Incyte Increases Turnover in the Second Quarter, Share Price Rises 6%

Biotech News | 30.07.2019

Our sample portfolio value Incyte today presented its annual report for the second quarter of 2019...

Biotech News Portfolio

Biotech Investments Model Portfolio: +26.7% as of 28 July 2019

Biotech News | 28.07.2019

The Model Portfolio of Biotech Investments developed extremely positively in the first seven months...

Macrogenics Portfolio Stock Recommendations

Macrogenics: Buy!

Biotech News | 26.07.2019

Macrogenics is an American biotech company focused on the development of innovative antibody...

Portfolio

Vivoryon Therapeutics

Biotech News | 10.07.2019

Vivoryion Therapeutics is a small-capitalized German pharmaceutical company headquartered in Halle,...

Portfolio

Vertex Pharmaceuticals

Biotech News | 10.07.2019

Vertex Pharmaceuticals is a US biopharmaceutical company headquartered in Boston, Massachusetts....

Portfolio

Sarepta Therapeutics

Biotech News | 10.07.2019

Sarepta Therapeutics is a US biotechnology company headquartered in Cambridge, Massachusetts. The...

Portfolio

Sangamo Therapeutics

Biotech News | 10.07.2019

Sangamo Therapeutics is a US biotechnology company headquartered in Richmond, California. The...

Portfolio

Sage Therapeutics

Biotech News | 10.07.2019

Sage Therapeutics is a US biopharmaceutical company headquartered in Cambridge, Massachusetts. The...

Portfolio

Macrogenics

Biotech News | 10.07.2019

Macrogenics is a US biotechnology company headquartered in Rockwille, Maryland. The company...

Portfolio

Kezar Life Sciences

Biotech News | 10.07.2019

Kezar Life Sciences is a small US biotech company headquartered in South San Francisco, California....

Portfolio

Ionis Pharmaceuticals

Biotech News | 10.07.2019

Ionis Pharmaceuticals is a US-based pharmaceutical company headquartered in Carlsbad, California....

Portfolio

Incyte

Biotech News | 10.07.2019

Incyte is a US pharmaceutical company headquartered in Alapocas, Delaware. The company already has...

Portfolio

Idorsia

Biotech News | 10.07.2019

Idorisa is a Swiss biopharmaceutical company headquartered in Allschwil, Basel-Land. The company...

Portfolio

Hutchison China Meditech (Chi-Med)

Biotech News | 10.07.2019

Hutchison China Meditech or Chi-Med for short is a Chinese biotech company headquartered in Hong...

Portfolio

Esperion Therapeutics

Biotech News | 10.07.2019

Esperion Therapeutics is a US-based pharmaceutical company headquartered in Ann Arbor, Michigan....

Portfolio

CRISPR Therapeutics

Biotech News | 10.07.2019

CRISPR Therapeutics is an investment company headquartered in Zug, Switzerland. However, the...

Portfolio

Corbus Pharmaceuticals

Biotech News | 10.07.2019

Corbus Pharmaceuticals is a small US pharmaceutical company based in Norwood, Massachusetts. The...

Portfolio

BeiGene

Biotech News | 10.07.2019

BeiGene is one of the best-known Chinese biotech companies with headquarters in Beijing. The...

Portfolio

Audentes

Biotech News | 10.07.2019

Audentes is a US biotech company headquartered in San Francisco, California, specializing in...

Portfolio

Argenx

Biotech News | 10.07.2019

Argenx is a small European biotechnology company headquartered in Breda, Holland. The company...

Portfolio

Alnylam Pharmaceuticals

Biotech News | 10.07.2019

Alnylam Pharmaceuticals is a US biopharmaceutical company headquartered in Cambridge,...

Portfolio

Alexion Pharmaceuticals

Biotech News | 10.07.2019

Alexion Pharmaceuticals is a biopharmaceutical company from the US headquartered in New Haven,...

Portfolio

Akcea Therapeutics

Biotech News | 10.07.2019

Akcea Therapeutics is a US-based pharmaceutical company headquartered in Cambridge, Massachsetts....

Portfolio

Agios Pharmaceuticals

Biotech News | 02.07.2019

Agios Pharmaceuticals is a US pharmaceutical company based in Cambridge, Massachusetts. The company...